A federal grant for HIV research is part of $15.7 million the National Institutes for Health awarded to the Wertheim UF ...

ExQor Technologies, a Boston MA based biotechnology company, is preparing for clinical trials for its proprietary brain regenerative medicine platform targeting Alzheimer's disease. Current ...

Uganda is one of just ten high-burden HIV countries where the drug will be distributed through the US President’s Emergency Plan for AIDS Relief (PEPFAR). The US initiative, which will promote large ...

For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating-and possibly even ...

Cuts proposed by the Trump administration and House Republicans could drive up new HIV cases by more than 200,000 by 2030, ...

For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating—and possibly even ...

Researchers at Case Western Reserve University identified for the first time how HIV enters a dormant state in infected cells that allows the virus to “hide” from the immune system and current ...

Being out of care doesn’t have to be permanent, and many people can restart HIV treatment. The sooner PWH restart treatment, ...

Zimbabwe has been chosen as one of only ten countries in the world to introduce lenacapavir, a revolutionary HIV prevention drug that health experts say could transform global efforts to end new ...

The number of people living with HIV in Bulawayo has declined from 79 711 in 2020 to 76 608 in 2024, as new infections continue to fall in response to significant progress in prevention and treatment.

Millions more people at risk of HIV in low- and middle-income countries (LMICs) will have access to a powerful new prevention option: a low-cost, generic ...